Response to chemotherapy after relapse in patients with or without previous adjuvant chemotherapy for breast cancer
- 1 April 1993
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 19, 21-30
- https://doi.org/10.1016/0305-7372(93)90004-b
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- A prospective randomized trial comparing epirubicin monochemotherapy to two fluorouracil, cyclophosphamide, and epirubicin regimens differing in epirubicin dose in advanced breast cancer patients. The French Epirubicin Study Group.Journal of Clinical Oncology, 1991
- A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group.Journal of Clinical Oncology, 1988
- The effect of prior adjuvant chemotherapy on survival in metastatic breast cancerJournal of Surgical Oncology, 1988
- Salvage treatment of patients suffering relapse after adjuvant CMF chemotherapyCancer, 1986
- Treatment of breast carcinoma recurrent after adjuvant chemoimmunotherapyJournal of Surgical Oncology, 1984
- Response to secondary therapy in patients with adenocarcinoma of the breast previously treated with adjuvant chemotherapyCancer, 1983
- Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimensCancer, 1981
- Chi-Square Tests with One Degree of Freedom; Extensions of the Mantel- Haenszel ProcedureJournal of the American Statistical Association, 1963
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958